Tag Archives: Nature Medicine

Studies: “Blood-Based ‘Liquid Health Check’ Beats Traditional Predictors of Multiple Disease Risks” (Nature)

From a Genetic Engineering & Biotechnology News release:

Nature Medicine Journal Dec 2019“This proof of concept study demonstrates a new paradigm that measurement of blood proteins can accurately deliver health information that spans across numerous medical specialties and that should be actionable for patients and their healthcare providers,” said Peter Ganz, MD, co-leader of this study and the Maurice Eliaser distinguished professor of medicine at UCSF and director of the Center of Excellence in Vascular Research at Zuckerberg San Francisco General Hospital and Trauma Center. 

Specific patterns of protein levels in our blood could be used to provide a comprehensive “liquid health check” that gives a snapshot of health and potentially an indication of the likelihood that we will develop certain diseases or health risk factors in the future, according to research by scientists in the U.S. and U.K. working with SomaLogic. The results of their proof-of-concept study involving more than 16,000 participants, and published in Nature Medicine, showed that while the accuracy of models based on specific protein expression patterns varied, they were all either better predictors than models based on traditional risk factors, or would constitute more convenient and less expensive alternatives to traditional testing.

Study published in Nature Medicine: https://www.nature.com/articles/s41591-019-0665-2

To read more: https://www.genengnews.com/news/blood-based-liquid-health-check-beats-traditional-predictors-of-multiple-disease-risks/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20191203&oly_enc_id=5678C5137845J4Z